Pfm Health Sciences, LP Exact Sciences Corp Transaction History

Pfm Health Sciences, LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 16, 2020	SELL	$72.92 - $102.01 $11.8 Million - $16.5 Million	-161,679 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$55.75 - $92.75 $9.01 Million - $15 Million	161,679 New	161,679 $14.1 Million
Q1 2020 May 15, 2020	SELL	$37.9 - $104.44 $7.95 Million - $21.9 Million	-209,839 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$77.66 - $99.74 $16.3 Million - $20.9 Million	209,839 New	209,839 $19.4 Million
Q3 2019 Nov 14, 2019	SELL	$90.37 - $122.49 $37.8 Million - $51.2 Million	-418,329 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$89.51 - $118.04 $13.3 Million - $17.5 Million	-148,030 Reduced 26.14%	418,329 $49.4 Million
Q1 2019 May 15, 2019	BUY	$61.98 - $96.5 $35.1 Million - $54.7 Million	566,359 New	566,359 $49.1 Million

676

162M

2.58M

2.19M

Ticker EXAS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 176,960,000
Market Cap $10.2B
Description
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...

Get notified when there are updates to the investment portfolio of Pfm Health Sciences, LP, based on Form 13F filings with the SEC.

Stay updated on Pfm Health Sciences, LP with notifications on news.